Jacqueline Bromberg

University of Maryland, Baltimore — United States

Medicine · Health Sciences

63h-index46.1kcitations203works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(60), Cancer Mechanisms and Therapy(20), Extracellular vesicles in disease(19), PI3K/AKT/mTOR signaling in cancer(19), Medical Imaging Techniques and Applications(18)

Publications202 total

No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort study
Journal of the American Academy of Dermatology·2025Open Access
Improving Quality of Life in Patients with Malignant Wounds: Outcomes from a Specialized Wound Care Clinic
Advances in Wound Care·2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding
Cancer Discovery·2025· 5 citedOpen Access
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer
Cancer Cell·2025· 9 citedOpen Access
PD-L1 Coupling with LTbR in Endothelial Cells Induces Tolerance
American Journal of Transplantation·2025
Lymph Node Scarring Prevents Allograft Survival by Altering Fibroblastic Reticular Cells
American Journal of Transplantation·2025· 1 citedOpen Access
Integration of Next Generation Sequencing Data to Inform Survival Prediction of Patients with Spine Metastasis
Cancers·2025· 1 citedOpen Access
Abstract PS6-01: The PARP inhibitor rucaparib is a strong radiosensitizer in women with residual triple-negative breast cancer treated concurrently with adjuvant radiotherapy
Clinical Cancer Research·2025
Once-Daily Postmastectomy Radiation Therapy Confers Excellent Locoregional Control for Inflammatory Breast Cancer
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy
JACC CardioOncology·2025· 7 citedOpen Access
Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2
Cell·2025· 35 citedOpen Access
Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
Nature Cancer·2024· 18 citedOpen Access
615 Intratumoral Fc-engineered agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in metastatic cancer patients. A bench-to-bedside and back approach
Regular and Young Investigator Award Abstracts·2024Open Access
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
npj Breast Cancer·2024· 8 citedOpen Access
Quality of Life in Patients with Malignant Wounds Treated at a Wound Care Clinic
2024· 2 citedOpen Access
Oral minoxidil for late alopecia in cancer survivors
Breast Cancer Research and Treatment·2024· 14 cited
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer
2024· 6 citedOpen Access
Quality of life in patients with malignant wounds treated at a wound care clinic.
Journal of Clinical Oncology·2024
Tumour-derived Extracellular Vesicle and Particle Reprogramming of Interstitial Macrophages in the Lung Pre-Metastatic Niche Enhances Vascular Permeability and Metastatic Potential
Research Square (Research Square)·2024· 2 citedOpen Access
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer
2024· 1 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

David Lyden(14), Irina Matei(9), Héctor Peinado(8), James Darnell(8), Ayuko Hoshino(7), Haiying Zhang(7), Bruno Costa‐Silva(6), Pasquale Sansone(6), Laura Daly(6), Marjan Berishaj(6), Caitlin Williams(5), John H. Healey(5), Vinagolu K. Rajasekhar(5), Kenneth Leslie(5), William L. Gerald(5), Gonçalo Rodrigues(4), Milica Tešić Mark(4), Henrik Molina(4), Linda Bojmar(4), Cyrus M. Ghajar(4)